EPKINLY
Live / Registered — Registered (as of 17 Oct 2023)
What this means for you
Registered since 17 Oct 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Oct 2029: the §8 declaration of use).
Record
- Serial number
- 97811274
- Registration number
- 7196305
- Mark type
- Design + words
- Filed
- 24 Feb 2023
- Published for opposition
- 01 Aug 2023
- Registered
- 17 Oct 2023
- Next maintenance filing
- §8 declaration of use, due by 17 Oct 2029 (grace period to 17 Apr 2030)
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
Owner
- GENMAB A/S, VALBY, DK
- AbbVie Biotechnology Ltd, Hamilton, BM
- AbbVie Biotechnology Ltd, Hamilton, BM
- AbbVie Biotechnology Ltd, Hamilton, BM
Prosecution history
- 08 May 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 08 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 May 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 08 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 May 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 May 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Aug 2023 — PUBLISHED FOR OPPOSITION
- 12 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 23 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER